Inositol hexakisphosphate (InsP 6 ) is a member of the inositol polyphosphate group that participates in numerous intracellular signaling pathways. My colleagues and I previously reported that InsP 6 stimulated double-strand break repair by nonhomologous end joining (NHEJ) in cell-free extracts and that InsP 6 binding by the Ku70/80 subunit of the DNA-dependent protein kinase (DNA-PK) was required for stimulation of NHEJ in vitro [1] [2] [3] . This report describes InsP 6 -dependent phosphorylation of two NHEJ factors, XRCC4 and XLF, in partially purified human cell extracts. XRCC4 and XLF are known substrates for DNA-PK, which does not require InsP 6 for protein kinase activity. Consistent with a role for DNA-PK in these reactions, While additional protein kinases may participate in InsP 6 -dependent phosphorylation of XRCC4 and XLF, data presented here describe a clear requirement for DNA-PK in these phosphorylation events. Furthermore, these data suggest that binding of the inositol polyphosphate InsP 6 by Ku70/80 may modulate the substrate specificity of the phosphoinositide-3 kinase related protein kinase DNA-PK.
Introduction
The inositol polyphosphates (InsPs) are a group of ubiquitous, structurally similar small molecules that differ from one another in the placement of phosphate and pyrophosphate groups around a 6-carbon inositol ring. Study of the kinases and phosphatases responsible for InsP metabolism has demonstrated that the InsPs play important roles in many cellular functions [4] [5] [6] [7] [8] . Of particular importance to this paper is inositol hexakisphosphate (InsP 6 ), which is phosphorylated at all 6 positions. Studies in mice have shown that the pathway responsible for InsP 6 biosynthesis is required for viability. For example, failure to express the inositol polyphosphate multikinase Ipk2, which produces the InsP 6 precursor InsP 5 , or the InsP 5 kinase that produces InsP 6 resulted in embryonic lethality [9, 10] . These reports indicate that production of the highly phosphorylated InsPs, InsP 6 in particular, are essential for growth and development, and exemplify the importance of the InsPs as a group. InsP 6 has been mechanistically linked to biologically important pathways such as chromatin remodeling [11, 12] , RNA editing [13] and mRNA export [14] [15] [16] [17] . The wellstudied role of InsP 6 in mRNA export has outlined a basic paradigm for the action of InsP 6 , which alters the structure and/or surface charge topology of an InsP 6 -binding protein that, in turn, modulates the activity of an enzyme. A variation of this paradigm is reflected in the regulation of casein kinase 2 (CK2) by InsP 6 , in which formation of an InsP 6 -CK2 complex prevents binding of the CK2 negative regulator nucleolar protein p140 [18] [19] [20] . Because a single protein kinase may act on several substrates, the discovery of CK2 regulation by InsP 6 sets an important precedence for a mechanism by which InsP 6 InsP 6 interacts with the regulatory subunit of a protein kinase that is a key participant in DNA double-strand break (DSB) repair by non-homologous end joining (NHEJ), which implicates InsP 6 as a co-factor in this important process [1] [2] [3] .
NHEJ plays an influential role in maintenance of genomic integrity. Studies of mammalian NHEJ employing mouse models have demonstrated that genomic stability depends upon the NHEJ mechanism and deficiencies in this pathway can lead to events that initiate or propagate tumorigenesis [21] . NHEJ rejoins DSBs during G0, G1
and early-S phases of the cell cycle and is therefore the dominant mechanism used for DSB repair in humans and other multicellular organisms. End joining is carried out by DNA ligase IV (ligase IV), which acts as part of the XLF/XRCC4/ligase IV complex [22] [23] [24] [25] [26] . In a direct display of the tumor-prevention function of the mammalian NHEJ apparatus Sharpless et al. [27] demonstrated that in tumor-prone mice, even a modest reduction in ligase IV production dramatically increased the accumulation of soft tissue sarcomas showing chromosomal rearrangements. Such data support the growing view that deficiencies in the NHEJ apparatus can provide a mechanism for the generation of oncogenic events that drive general mammalian tumorigenesis.
XRCC4 directly interacts with ligase IV and XLF and is required for stability and catalytic activity of the ligase [25] . All members of this complex are required for NHEJ in vivo and deficiency in XLF, XRCC4 or ligase IV results in a loss of NHEJ in cells [22] [23] [24] [25] [26] . Given the central role of the XLF/XRCC4/ligase IV complex in end joining, modification of XLF, XRCC4 or ligase IV has the potential to significantly impact NHEJ. 6 phosphoinositide-3 kinase-related protein kinase (PIKK) DNA-PK catalytic subunit (DNA-PKcs) and the heterodimeric Ku70/80 regulatory subunit [28] . Knockout studies in mice have shown that all three components of DNA-PK are required for NHEJ in vivo and deficiency in DNA-PKcs, Ku70 or Ku80 results in genomic instability, immunodeficiency and radiosensitivity [28] [29] [30] . Because the catalytic activity of DNA-PK is required for NHEJ in vivo, inhibitors of DNA-PK radiosensitize cells and have potential as chemotherapeutic agents [28, 31] . While DNA-PK has been shown to act on the known NHEJ factors, many of which are phosphorylated in response to DNA damage, the biological roles of these phosphorylation events remain an open question [25] .
DNA-PK has been shown to bind InsP 6 , which acts as a stimulatory cofactor for NHEJ in vitro [2] . The Ku70/80 heterodimer was later identified as the InsP 6 -binding component of DNA-PK [1, 32] . These observations were followed by the demonstration that Ku70/80 mobility was reduced in cells depleted of InsP 6 through treatment with calmodulin inhibitors, [33] and that InsP 6 binding by Ku70/80 is necessary for stimulation of NHEJ in vitro [3] . Taken together these findings are consistent with the hypothesis that InsP 6 binding by Ku70/80 acts to potentiate one or more steps in DNA-PK-dependent DNA repair by NHEJ.
In assays using partially purified human-cell extracts, InsP 6 -dependent stimulation of NHEJ was coincident with InsP 6 -dependent phosphorylation of the NHEJ factors XRCC4 and XLF. These InsP 6 -dependent phosphorylation events required DNA-PK activity and, most significantly, InsP 6 -binding by Ku70/80. Because Ku70/80 is the regulatory subunit of DNA-PK, these data imply that phosphorylation of NHEJ factors by DNA-PK may be modulated by InsP 6 . 
Materials and Methods

Reagents
Tyrosine Phosphatase Inhibitor Cocktail (Upstate). Okadiac acid (Roche).
Ku55933 and Nu7026 were a generous gift from Graham Smith, KuDos Pharmaceuticals, Astrazeneca. Expression and purification of recombinant Ku70/80 (wild type and Ku70DM/80TM) were performed as previously described [3] . The PhosphoProtein Purification Kit (Qiagen) was used to isolate phosphorylated proteins as per manufacturers instructions.
Rabbit polyclonal anti-XLF antibodies
Full-length human XLF in the plasmid pGEX-XLF (a generous gift from Steve Jackson, Cambridge, UK) was subject to direct DNA sequencing to confirm the sequence of human XLF then transformed into E. coli strain Rosetta 2 (Novagen). Cells were grown to log phase, cooled to 18ºC, induced with 0.25 mM IPTG for 18 hours then collected by centrifugation and pellets were stored at -80ºC. Cells were resuspended in Buffer A (50 mM tris pH 8.0, 5 mM EDTA, 0.8 M NaCl, 0.1% Triton X-100) with 1 mM DTT, 1 mM PMSF, 1 mM Benzamidine with 1x Complete Mini EDTA-free protease inhibitor cocktail (Roche) and lysed by sonication. Cell debris was removed by centrifugation and the resulting lysate was bound in batch to GST-sepharose (GE) for 1 hour on ice with gentle agitation. The resulting mixture was packed into a column, 0.5 mM EDTA) with 50 mM NaCl and 1 mM DTT. Following dialysis the sample was fractionated over a 1 ml Hi-trap Q column (GE) in buffer B and eluted with a 50 mM to 1M NaCl linear gradient. Peak fractions were pooled, resolved on preparative SDS-PAGE and bands corresponding to full-length GST-XLF were excised and used as implants to immunize two New Zealand White Rabbits (JHU08 and JHU09) for antibody production. JHU08 antiserum was suitable for XLF immunoprecipitation (IP) and JHU09 antiserum was suitable for Western blot detection.
Large-scale extract preparation
Whole-cell extract was prepared essentially as previously described [34] . Briefly, HeLa cells were grown in suspension, 5 x 10 Step-elution (L buffer, 0.3 M KCl) was used to collect phosphocellulose-bound proteins, which were precipitated with 65% ammonium sulphate to concentrate the protein sample, which was dialyzed against L buffer with 0.1 M KOAc before being snap frozen on liquid nitrogen then stored at -80°C. Protein concentration: 15-20 mg/ml by Bradford assay.
Small-scale extract preparation
Small-scale whole-cell extract was prepared from MO59J and MO59K cells essentially as previously described for 120 min mini-NHEJ extracts [35] . Briefly, adherent cells were harvested at 70-80% confluency using a cell scraper, collected Reactions were carried out essentially as previously described [2] . Briefly, 10 µl reactions that contained 50 mM HEPES pH 8.0, 0.1 M KOAc, 0.5 mM Mg(OAc) 2 , 1 mM ATP, 1 mM DTT, 0.1 mg/ml BSA, 0.6 mg/ml partially purified extract and 10 ng 32 Plabeled Hind III-linearized pBlueScript were incubated for 1 hour at 37ºC. DNA products were deproteinized by treatment with proteinase K and SDS, separated by agarose gel electrophoresis (0.6%, TAE) then visualized by autoradiography.
XRCC4 phosphorylation
Reactions were carried out using the same conditions as described for DNA end joining using unlabeled DNA as substrate. Reactions were terminated by the addition of 4x protein sample loading buffer and resolved on 9.4% 21.1:1 acrylamide:bis SDS-PAGE gels, which were run for 160 min at 150V when the 45 kDa marker reached the bottom of the gel. Samples were transferred to PVDF membrane (Immobilon P) and XRCC4 was detected using anti-XRCC4 rabbit polyclonal antiserum (Serotec) at 1:2000 dilution.
XLF phosphorylation
100 µl reactions were carried out as described for DNA end joining using P was detected by phosphoimager after which XLF was detected using anti-XLF rabbit polyclonal antiserum (JHU09) at 1:1000 dilution.
Results
InsP 6 -dependent XRCC4 phosphorylation
My colleagues and I previously reported mutational analysis of Ku70/80, which showed that Ku70/80 proteins with reduced affinity for InsP 6 (InsP 6 -binding mutants)
were impaired for participation in NHEJ in vitro [3] . Because Ku70/80 is an important functional part of DNA-PK, binding of InsP 6 might affect the ability of DNA-PK to phosphorylate protein targets. To test the hypothesis that InsP 6 may affect DNA-PK phosphorylation of full-length protein substrates, the effect of 1 µM InsP 6 on phosphorylation of the DNA-PK substrate XRCC4 [36, 37] was observed during the course of a DNA end-joining reaction. As shown in Figure 1A (sodium orthovanadate, sodium molybdate, sodium tartrate and imidazole) or to the inhibitor of serine/threonine protein phosphatase 1 (PP1) and 2A (PP2A), okadiac acid (data not shown). Taken together, data presented in Figure 1 illustrates InsP 6 -dependent XRCC4 phosphorylation that correlated with DNA end joining.
InsP 6 -dependent XRCC4 phosphorylation requires DNA-PK activity
XRCC4 is a known substrate for the protein kinase DNA-PK [36, 37] and Ku70/80, the DNA-binding subunit of DNA-PK, is an InsP 6 -binding protein [1, 32] .
Together, these published observations suggested that DNA-PK activity might be required for InsP 6 -dependent XRCC4 phosphorylation. This hypothesis was tested by examining of the sensitivity of XRCC4 InsP 6 -dependent phosphorylation to the general PIKK inhibitor wortmannin [39-41]. Wortmannin inhibited both accumulation of lowmobility (e.g. phosphorylated) forms of XRCC4 and DNA-PK-dependent DNA end joining ( Fig. 2A) , and similar results were obtained with the general PIKK inhibitor LY29004 [39] (data not shown). These data implicate a member of the PIKK family in InsP 6 -dependent phosphorylation of XRCC4, which is consistent with a role for DNA-PK in InsP 6 -dependent XRCC4 phosphorylation.
Significantly, a control reaction that lacked double-stranded DNA (dsDNA) and InsP 6 showed no evidence of low-mobility XRCC4 ( Fig. 2A, top) . These data suggested a requirement for dsDNA in XRCC4 phosphorylation. To directly assess the role of DNA in XRCC4 phosphorylation, reactions were carried out with various amounts of linear dsDNA. As shown in Figure 2B To determine if DNA-PKcs is required for InsP 6 -dependent XRCC4 phosphorylation end-joining reactions were carried out using extracts prepared from DNA-PKcs wild type or DNA-PKcs-deficient cells.
A comparison of XRCC4 phosphorylation in end-joining reactions that contained DNA-PKcs wild type HeLa and MO59K cell extracts or DNA-PKcs-deficient MO59J cell extracts is shown in Figure 2C .
Both low-mobility form of XRCC4 were observed in the presence of InsP 6 in reactions containing DNA-PKcs wild type cell extracts, but not in reactions carried out with extracts prepared from DNA-PKcs-deficient cells (Fig. 2C) .
While the data presented in Figure 2C ataxia-telangiectasia mutated (ATM) protein kinase [42] , which also functions in DSB repair. To determine whether the results in Figure 2C reflected a requirement for DNAPKcs or for ATM, XRCC4 phosphorylation reactions were carried out in the presence of DNA-PKcs-or ATM-specific inhibitors. The DNA-PKcs-specific inhibitor Nu7026, which exhibits minimal off-target effects (IC50: DNA-PK, 230 nM; ATM >100 µM), has been described previously and used in the investigation of DNA-PK activity [43] [44] [45] . To corroborate the results presented in Figure 2C , XRCC4 phosphorylation reactions were treated with Nu7026, which markedly reduced XRCC4 phosphorylation (Fig. 2D, top) . In contrast, treatment with the ATM-specific inhibitor Ku55933 [46] had no effect on phosphorylation of XRCC4 (Fig. 2D, bottom) . Taken together the data in Figure 2 clearly demonstrate a requirement for DNA-PK activity in InsP 6 -dependent phosphorylation of XRCC4, and go on to implicate DNA-PKcs as an InsP 6 -responsive protein kinase.
DNA-PK-, InsP 6 -dependent phosphorylation of XLF
XRCC4 is known to interact functionally with ligase IV and XLF to form the XLF/XRCC4/ligase IV complex [22] [23] [24] [25] [26] . As XRCC4 is subject to InsP 6 -dependent phosphorylation other members of the XLF/XRCC4/ligase IV complex might similarly be phosphorylated in response to InsP 6 . To assess the effect of InsP 6 on phosphorylation of ligase IV and XLF, phosphorylation reactions were carried out in the presence, or absence, of InsP 6 , after which phosphorylated proteins were isolated and Western blot analysis was used to detect ligase IV and XLF in the phosphoprotein fraction. 
containing high salt (1 M NaCl) and detergent (0.25% CHAPS) to abrogate proteinprotein and protein-DNA interactions. Following dilution, samples were loaded onto a PhosphoProtein column (Qiagen) for collection of phosphorylated proteins. As shown in Figure 3A , ligase IV and XRCC4 were retained on the PhosphoProtein column under all conditions. These results indicate that XRCC4 and ligase IV were present in the input extract as phosphoproteins, modified in a dsDNA-, InsP 6 -independent manner, or both.
In the absence of dsDNA, XLF was not retained on the PhosphoProtein column.
Significantly, XLF did not co-fractionate with ligase IV and XRCC4 under these conditions, which indicated that XLF had separated from the XLF/XRCC4/ligase IV complex and was fractionating independent of XRCC4 and ligase IV. A small amount of XLF was retained on the PhosphoProtein column when reactions contained dsDNA and retention increased when reactions also contained InsP 6 . These data show DNAdependent XLF phosphorylation that increased in the presence of InsP 6 .
To confirm that XLF phosphorylation was stimulated by InsP 6 , reactions were carried out in the presence of [γ 32 P]ATP, anti-XLF antibodies were used to immunoprecipitate (IP) XLF and the immune complexes were examined for evidence of 32 P-labeled XLF. Figure 3B shows the results of the XLF IP (top) and phosphorimager analysis (bottom), which demonstrate radiolabeling of a 37 kD species that immunoprecipitated with anti-XLF antibodies and co-migrated with XLF and is therefore believed to be XLF. Data in Figure 3B show that the 37 kD species was phosphorylated in the absence of InsP 6 , which may represent InsP 6 -independent phosphorylation or InsP 6 -dependent phosphorylation that was stimulated by residual endogenous InsP 6 in the reaction. Importantly, Figure 3B shows that phosphorylation increased with the 
addition of 1 µM exogenous InsP 6 . It is worth noting that these data cannot unequivocally identify the 37 kD species that is phosphorylated in response to InsP 6 as XLF and it is plausible that the radiolabeled species shown in Figure 3B is not XLF.
Given the low probability that a completely unrelated polypeptide would be recognized by anti-XLF antibodies and co-migrate with XLF to yield the data presented in Figures   3A and 3B the 37 kD radiolabeled species will be referred to as XLF throughout this manuscript. Figure 3C shows that phosphorylation of XLF (top) was specifically stimulated by InsP 6 , but not by IS 6 and that IP of XLF was consistent for all reactions (bottom). In aggregate, data in Figure 3 show that phosphorylation of XLF is specifically stimulated by InsP 6 and provide evidence for InsP 6 -dependent phosphorylation of XLF.
Data presented in Figures 1 and 2 provide evidence for InsP 6 -, DNA-PKdependent phosphorylation of XRCC4. Like XRCC4, XLF is a substrate for DNA-PK [47] and InsP 6 -dependent phosphorylation of XLF might require also DNA-PK activity. InsP 6 -dependent phosphorylation of XLF required dsDNA (Fig. 4A) and was sensitive to treatment with the general PIKK inhibitors wortmannin (Fig. 4B ) and LY29004 (data not shown), which is consistent with a requirement for DNA-PK. Similarly, addition of the DNA-PKcs-specific inhibitor Nu7026 to XLF phosphorylation reactions markedly reduced XLF phosphorylation (Fig. 4C) . In contrast, treatment with the ATM-specific inhibitor Ku55933 had no effect on phosphorylation of XLF (Fig. 4D) . Taken together, the data presented in Figure 4 show that DNA-PK activity is required for InsP 6 -dependent phosphorylation of XLF. binding by Ku70/80, which is the DNA-binding subunit of DNA-PK, is required for InsP 6 stimulation of NHEJ in vitro [3] . That study described the Ku70DM/80TM mutant, which carries five site-specific lysine-to-alanine mutations in the InsP 6 -binding site of Ku70/80 [3] . These mutations reduce InsP 6 -binding by Ku70DM/80TM to 1.22% of wild type, but did not affect the ability of the protein to bind DNA or to participate in DNA-PK phosphorylation of a peptide substrate [3] . Here, Ku70DM/80TM was used to assess the role of InsP 6 binding by Ku70/80 in InsP 6 -dependent phosphorylation of XRCC4 and XLF. Briefly, endogenous Ku70/80 was removed from partially purified human cell extracts by immunodepletion to create Ku70/80-depleted extracts, which were complemented with purified recombinant Ku70/80 proteins, wild type or Ku70DM/80TM, and used in XRCC4 and XLF phosphorylation reactions.
As shown in Figure 5A , immunodepletion of Ku70/80 (lanes 1 and 2) resulted in significant reduction of XRCC4 modification, while mock depletion, with no anti-Ku70/80 antibodies, had no effect on XRCC4 phosphorylation (lanes [8] [9] [10] . These data demonstrate a requirement for Ku70/80 in InsP 6 -dependent phosphorylation of XRCC4, which is consistent with a requirement for DNA-PK. Addition of purified recombinant wild type Ku70/80 (lanes 3 and 4) restored InsP 6 -dependent and -independent XRCC4 modification and demonstrated that the lack of phosphorylation observed in Ku70/80- How might InsP 6 modulate DNA-PK activity? Three basic models for InsP 6 regulation of enzymatic activity have been reported in biologically relevant systems. In the first model, direct binding of InsP 6 by an enzyme regulates catalytic activity. This is exemplified by the RNA editing enzyme ADAR2, which requires binding of InsP 6 for adenosine deaminase activity [13] . In this instance, InsP 6 is bound in the ADAR2 core where a large number of hydrogen bonds between InsP 6 and ADAR2 are formed and presumably stabilize the protein fold [13] . This study showed that the structurally similar tRNA deaminase ADAT1 also required InsP 6 for catalytic activity [13] . Together, ADAR2
and ADAT1 show how binding of InsP 6 by an enzyme can directly regulate its catalytic activity.
In the second model, binding of InsP 6 by an enzyme does not directly affect catalytic activity, but affects binding of regulatory factors, that influence enzymatic activity. As previously noted, InsP 6 has been shown to regulate binding of CK2 by the CK2 negative regulator nucleolar protein p140 [18] [19] [20] . Binding of InsP 6 by CK2 prevents formation of inactive CK2-p140 complexes, thereby preserving CK2 activity [18] [19] [20] . In the above examples, enzymatic activity varies in response to the amount of InsP 6 in a given reaction. DNA-PK is catalytically active in the presence and absence of InsP 6 , and phosphorylation of a p53-peptide substrate by DNA-PK containing either the InsP 6 -binding mutant Ku70DM/80TM or wild type Ku70/80 was comparable [3] . Yet 
interactions of kinases with ATP generally involves structural motifs that are common amongst protein kinases, the repertoire of interactions with the protein substrate is diverse and is rendered even more complex by participation of regulatory subunits. 
